EXCEL

Investigator: Alpesh Shah, MD

Study Coordinator: Mary Mata

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01205776

Phone: 713.441.5981

IRB Number: Pro00005823

Description

To establish the safety and efficacy of the XIENCE PRIME or XIENCE V Everolimus Eluting Coronary Stent System (EECSS) in subjects with unprotected left main coronary artery disease by comparing to coronary artery bypass graft surgery
More to Explore